BDNF levels in parietal cortex homogenates of pathologically confirmed AD patients (Braak staging V–VI) were decreased by ~50% compared with age- and sex-matched HE controls, as quantified using ELISA (Figure 1c) and western blot analyses (Figure 1d, e). The gene discussed is BDNF; the disease is Alzheimer disease.